跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,770 条关于
“PPAR agonists”
全部
2,770
临床试验
1,220
药物
576
机构
9
资讯
965
去年
New PPAR Agonists Expand Treatment Landscape for Primary Biliary Cholangitis
去年
PPAR-gamma Pathway Modulation Enhances NECTIN4-Targeted CAR-T Therapy for Bladder Cancer
去年
Inventiva's Lanifibranor Shows Promise in Reversing Liver Vascular Damage in MASH Patients
7个月前
Inventiva's Lanifibranor Achieves Dual Endpoints in NASH Trial, Analysts Project $2.6B Peak Sales
去年
NASH Pipeline Shows Promise with 80+ Emerging Therapies in Development
去年
FDA Grants Accelerated Approval to Ipsen's Iqirvo, First Dual PPAR Agonist for Primary Biliary Cholangitis
上个月
Meitheal Pharmaceuticals Announces FDA Approval of Garzulys™ (insulin aspart-fsan), a Biosimilar to NovoLog
3个月前
HkeyBio Launches Comprehensive Autoimmune Disease Model Platform for Drug Development
2个月前
NASH Treatment Market Accelerates as Rezdiffra and Wegovy Establish Fibrosis-Defined Drug Pathways
去年
Lanifibranor Shows Promise in Phase 3 MASH Trial with Improved Liver Health Biomarkers
第 1 页,共 97 页
上一页
下一页